FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.

FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.

Item
http://www.wikidata.org/entity/Q37086095
FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancerMicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.Cadherins Associate with Distinct Stem Cell-Related Transcription Factors to Coordinate the Maintenance of Stemness in Triple-Negative Breast Cancer.A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors.Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.Roles of FoxM1 in cell regulation and breast cancer targeting therapy.Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypesCalyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation.Urokinase-type plasminogen activator receptor inhibits apoptosis in triple-negative breast cancer through miR-17/20a suppression of death receptors 4 and 5.Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis.Modified gold-based siRNA nanotherapeutics for targeted therapy of triple-negative breast cancer.FoxM1 is a promising candidate target in the treatment of breast cancer.FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma
P2860

FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.

Item
http://www.wikidata.org/entity/Q37086095
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FOXM1 regulates expression of ...... negative breast cancer cells.
@en
FOXM1 regulates expression of ...... negative breast cancer cells.
@nl
type
label
FOXM1 regulates expression of ...... negative breast cancer cells.
@en
FOXM1 regulates expression of ...... negative breast cancer cells.
@nl
prefLabel
FOXM1 regulates expression of ...... negative breast cancer cells.
@en
FOXM1 regulates expression of ...... negative breast cancer cells.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
FOXM1 regulates expression of ...... negative breast cancer cells.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932